My primary focus is small Market Cap Bio Tech companies with intriguing pipelines that have large growth potential. I attempt to hold >50% of positions as LONG unless there is negative data, mgmt. concerns, or known negative events.
Entrepreneur, former fund manager, active independent trader, trading mostly the US equity market via stocks, ETFs and options, following closely the syndicate calendar for IPOs and secondary deals. Frenchman. Active in markets for more than 15 years
Individual investor. Former Investor Relations & Senior Editor of "The Wall Street Digest," an investment newsletter published for 32 years by Donald H. Rowe. (Publisher & newsletter both retired in mid-2009.)
Student at GMU studying Finance. Equities swing trader who occasionally trades intraday as well. I've only been trading for about 4 years now, and I'm still trying to find my way in this market like everyone else.